Skip to content
SQM

Sociedad Quimica y Minera de Chile SA

Sociedad Quimica y Minera de Chile SA Q3 FY2026 earnings call

November 18, 2026 · fiscal period ended 2026-09

EPS · actual vs est

$1.91 / $1.97Miss -3.0%

Revenue · actual vs est

$2.11B / $2.20BMiss -4.0%
Ask about this call

Summary

Generated 2026-11-18

Management highlights

Financial performance and discipline

  • Management reported approximately $1.6 billion in net income for the first three quarters of 2026, nearly four times the comparable 2025 figure. The transcript does not specify the currency for this amount.
  • The company said it remains financially disciplined and focused capital spending on areas where it believes it has competitive advantages.

Lithium market and strategy

  • Management sees healthy demand across electric vehicles (EVs) and battery energy storage systems (BESS), with broader demand beyond China and rising lithium content per vehicle also supporting growth.
  • It estimates 2026 global lithium-demand growth at approximately 30% and expects demand to exceed 3 million metric tons by 2030. Management said most 2026 growth reflects end-customer consumption, alongside declining inventories.
  • Management believes current lithium prices are below the incentive level needed to bring sufficient new supply to market, and expects prices to rise, though it cannot predict when.
  • Sodium-ion may capture some market niches, but management sees lithium as advantaged in cost and energy density.

Operations and investment

  • Novandino is targeting efficiency improvements and higher recovery to lift 2027 production to slightly above 300,000 metric tons.
  • Mount Holland’s concentrator is at or above nameplate capacity. The lithium hydroxide refinery ramp-up is progressing, with battery-grade quality improving monthly; allocation between refinery feed and direct spodumene sales is still under review.
  • Management maintained its capital plan despite current lithium prices. It expects approximately $3 billion of CapEx over 2026–2028, with 2026 spending slightly below the roughly $1 billion annual average.

Other businesses

  • Iodine demand is driven mainly by X-ray contrast media; management expects global demand growth above 3% in both 2026 and 2027.
  • SPN pricing trends remain positive, but higher fertilizer prices are affecting customer demand across markets. Higher phosphate prices particularly weighed on phosphate and phosphate-based NPK sales.
View in transcript ↓

Segment performance

The transcript provides no consolidated quarterly revenue or segment-revenue figures, so revenue contribution percentages cannot be calculated.

  • Lithium: Both lithium divisions performed in line with expectations. Novandino produced approximately 75,000 metric tons in Q3, similar to Q2; full-year 2026 production is expected near 290,000 metric tons. International Lithium’s Mount Holland concentrator is operating at or slightly above nameplate capacity; 2026 production guidance remains 175,000–185,000 metric tons of 6% spodumene concentrate. Management reported competitive costs: Novandino’s Q3 costs were similar to Q2 and below the prior year, while International Lithium costs remained stable.
  • Iodine: Management described solid performance, supported by healthy demand and favorable pricing, but disclosed no segment revenue or production figures.
  • Specialty plant nutrition (SPN): Commercial activity remained good, with strong sales in traditional markets. Higher fertilizer prices weighed on volumes; management revised full-year sales-volume growth expectations to approximately 5% year over year. Phosphates and phosphate-based NPK products faced the greatest pressure, partly offset by stronger potassium nitrate sales.
  • Potash: Primarily supports potassium nitrate production, with remaining availability sold to the market. Management expects 2027 commercial volumes to be lower than 2026, without giving a specific target.
View in transcript ↓

Guidance

  • Lithium demand: Approximately 30% global growth in 2026; management expects 2027 demand of about 2.5 million metric tons, implying 15%–20% growth. BESS demand is expected to grow around 15% in 2027, with EV demand described as broadly in the same 15%–20% range. Demand is projected to exceed 3 million metric tons by 2030.
  • Novandino lithium production: Approximately 290,000 metric tons in 2026, rising to slightly above 300,000 in 2027, supported by efficiency and recovery initiatives. Q3 production was close to 75,000 metric tons.
  • Lithium sulfate: Expected production of 160,000 in 2026, equivalent to about 80,000 metric tons of lithium carbonate; a modest increase is expected in 2027. The transcript does not specify the unit for the sulfate figure.
  • Mount Holland: 2026 spodumene concentrate production guidance remains 175,000–185,000 metric tons at 6% grade. The concentrator is expected to continue operating at nameplate capacity or slightly above in 2027. Direct sales versus refinery feed volumes remain undecided.
  • Lithium costs: Novandino expects Q4 2026 and 2027 costs to remain near Q2–Q3 levels and below 2025; International Lithium reported stable costs and expects the expansion to lower unit costs over time.
  • CapEx: No change to the plan was announced. CapEx for 2026–2028 remains approximately $3 billion in total; 2026 is expected to be slightly below the average annual spend.
  • Iodine: Demand growth expected to exceed 3% in 2026 and 2027.
  • SPN: Full-year 2026 sales-volume growth outlook was revised to approximately 5% year over year.
  • Potash: 2027 market-sale volumes are expected to be below 2026, but the company has not set a specific level.
View in transcript ↓

Risks

  • Lithium prices have fallen substantially from mid-year levels, and the timing of any recovery is uncertain. Management’s positive price outlook depends on anticipated demand growth and its view that current prices are below the level needed to incentivize adequate new supply.
  • Lithium-market uncertainty includes inventory levels and sentiment about future growth. Management cited lower inventories and end-customer demand, but did not provide detailed inventory figures.
  • BESS economics and possible sodium-ion penetration were raised as demand risks. Management remained confident in BESS and believes sodium-ion will have limited niches, but these remain market uncertainties.
  • Higher fertilizer prices are reducing SPN customer demand and volumes, especially for phosphate and phosphate-based NPK products. Management expects 2026 volume growth of about 5%, below its prior outlook, and did not quantify how quickly demand might recover.
  • Potash availability and 2027 sales volumes depend on Novandino production and the company’s priority of supplying potassium nitrate; commercial volumes are expected to decline year over year.
  • Mount Holland refinery ramp-up and the division’s product mix remain under planning, creating uncertainty around the split between hydroxide production and direct spodumene sales.
  • Management said its CapEx schedule remains intact despite lower-than-expected spending to date; project delivery and spending cadence remain dependent on project schedules.
  • The company’s forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially; management disclaimed any obligation to update them except as required by law.
View in transcript ↓

Q&A highlights

Q: How much of 2026 lithium-demand growth is end use, and what does management expect in 2027, including BESS and sodium-ion? / A: Management said most of the estimated 30% 2026 growth is end-customer consumption, with inventories declining. It expects 2027 demand growth of 15%–20%, including roughly 15% BESS growth; EV growth is expected in a similar range. Sodium-ion may take limited niches, but management sees lithium as advantaged in cost and energy density.

Q: What are Novandino’s lithium production expectations? / A: Q3 production was about 75,000 metric tons, and 2026 production is expected near 290,000. Efficiency and recovery improvements are expected to lift 2027 output slightly above 300,000 metric tons.

Q: Will lower lithium prices change CapEx, and why maintain the investment plan? / A: Management said it has not changed its plan, citing competitive advantages and confidence in long-term prospects. The 2026–2028 program remains approximately $3 billion, with 2026 spending slightly below the annual average.

Q: What is driving SPN volume weakness, and is it concentrated in particular markets? / A: Management said the impact of higher prices is broad across its more than 100 markets, rather than concentrated in one region. Phosphates and phosphate-based NPK products were most affected, partly offset by potassium nitrate sales.

Q: How will Mount Holland output be allocated between spodumene sales and lithium hydroxide? / A: The concentrator is expected to produce 175,000–185,000 metric tons of 6% concentrate in 2026 and continue at or above nameplate next year. The refinery ramp-up is progressing, but next year’s direct-sales versus refinery-feed mix remains under planning.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$1.91$1.97-3.0%$0.63
Revenue$2.11B$2.20B-4.0%$1.17B

Transcript

November 18, 2026

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.